Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Skeletal Radiology
Published in: Skeletal Radiology 11/2007

Open Access 01-11-2007 | Review Article

Magnetic resonance imaging of bone marrow in oncology, Part 2

Authors: Sinchun Hwang, David M. Panicek

Published in: Skeletal Radiology | Issue 11/2007

Login to get access

Abstract

Magnetic resonance imaging plays an integral role in the detection and characterization of marrow lesions, planning for biopsy or surgery, and post-treatment follow-up. To evaluate findings in bone marrow on MR imaging, it is essential to understand the normal composition and distribution of bone marrow and the changes in marrow that occur with age, as well as the basis for the MR signals from marrow and the factors that affect those signals; these points have been reviewed and illustrated in part 1 of this two-part article. Part 2 will emphasize the practical application of MR imaging to facilitate differentiation of normal marrow, tumor, and treatment-related marrow changes in oncology patients, and will review complementary MR techniques under development.
Literature
1.
Stabler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF. Contrast enhancement and quantitative signal analysis in MR imaging of multiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. Am J Roentgenol 1996; 167: 1029–1036.
2.
3.
Pennaforte JL, Dufour M, Etienne JC, Schvartz H, Caulet T.Diagnostic problems of bone marrow necrosis. Apropos of a case disclosing acute leukosis. Arch Anat Cytol Pathol 1986; 34: 111–116.PubMed
4.
Dunn P, Shih LY, Liaw SJ, Sun CF. Bone marrow necrosis in 38 adult cancer patients. J Formos Med Assoc 1993; 92: 1107–1110.PubMed
5.
Tang YM, Jeavons S, Stuckey S, Middleton H, Gill D. MRI features of bone marrow necrosis. Am J Roentgenol 2007; 188: 509–514.CrossRef
6.
Moulopoulos LA, Dimopoulos MA, Smith TL, et al. Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 1995; 13: 251–256.PubMed
7.
Vande Berg BC, Lecouvet FE, Michaux L, et al. Stage I multiple myeloma: value of MR imaging of the bone marrow in the determination of prognosis. Radiology 1996; 201: 243–246.PubMed
8.
Lecouvet FE, Vande Berg BC, Michaux L, et al. Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 1998; 209: 653–660.PubMed
9.
Varan A, Cila A, Büyükpamukçu, M. Prognostic importance of magnetic resonance imaging in bone marrow involvement of Hodgkin disease. Med Pediatr Oncol 1999; 32: 267–271.PubMedCrossRef
10.
Linden A, Zankovich R, Theissen P, Diehl V, Schicha H. Malignant lymphoma: bone marrow imaging versus biopsy. Radiology 1989; 173: 335–339.PubMed
11.
Coller BS, Chabner BA, Gralnick HR. Frequencies and patterns of bone marrow involvement in non-Hodgkin lymphomas: observations on the value of bilateral biopsies. Am J Hematol 1977; 3: 105–119.PubMed
12.
Brunning RD, Bloomfield CD, McKenna RW, Peterson L. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 1975; 82: 365–366.PubMed
13.
Rahmouni A, Montazel JL, Divine M, et al. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging. Radiology 2003; 229: 710–717.PubMedCrossRef
14.
Schweitzer ME, Levine C, Mitchell DG, Gannon FH, Gomella LG. Bull’s-eyes and halos: useful MR discriminators of osseous metastases. Radiology 1993; 188: 249–252.PubMed
15.
Yamaguchi T. Intertrabecular vertebral metastases: metastases only detectable on MR imaging. Semin Musculoskelet Radiol 2001; 5: 171–175.PubMedCrossRef
16.
Taoka T, Mayr NA, Lee HJ, et al. Factors influencing visualization of vertebral metastases on MR imaging versus bone scintigraphy. Am J Roentgenol 2001; 176: 1525–1530.
17.
Khurana JS, Rosenthal DI, Rosenberg AE, Mankin HJ. Skeletal metastases in liposarcoma detectable only by magnetic resonance imaging. Clin Orthop Relat Res 1989; 243: 204–207.
18.
Islam A, Catovsky D, Galton DA. Histological study of bone marrow regeneration following chemotherapy for acute myeloid leukaemia and chronic granulocytic leukaemia in blast transformation. Br J Haematol 1980; 45: 535–540.PubMed
19.
Sacks EL, Goris ML, Glatstein E, Gilbert E, Kaplan HS. Bone marrow regeneration following large field radiation: influence of volume, age, dose, and time. Cancer 1978; 42: 1057–1065.PubMedCrossRef
20.
Sykes MP, Chu FC, Wilkerson WG. Local bone-marrow changes secondary to therapeutic irradiation. Radiology 1960; 75: 919–924.PubMed
21.
Yankelevitz DF, Henschke CI, Knapp PH, Nisce L, Yi Y, Cahill P. Effect of radiation therapy on thoracic and lumbar bone marrow: evaluation with MR imaging. Am J Roentgenol 1991; 157: 87–92.
22.
Blomlie V, Rofstad EK, Skjonsberg A, Tvera K, Lien HH. Female pelvic bone marrow: serial MR imaging before, during, and after radiation therapy. Radiology 1995; 194: 537–543.PubMed
23.
Ramsey RG, Zacharias CE. MR imaging of the spine after radiation therapy: easily recognizable effects. Am J Roentgenol 1985; 144: 1131–1135.
24.
Stevens SK, Moore SG, Kaplan ID. Early and late bone-marrow changes after irradiation: MR evaluation. Am J Roentgenol 1990; 154: 745–750.
25.
Otake S, Mayr NA, Ueda T, Magnotta VA, Yuh WTC. Radiation-induced changes in MR signal intensity and contrast enhancement of lumbosacral vertebrae: do changes occur only inside the radiation therapy field? Radiology 2002; 222: 179–183.PubMedCrossRef
26.
Dalinka MK, Edeiken J, Finkelstein JB. Complications of radiation therapy: adult bone. Semin Roentgenol 1974; 9: 29–40.PubMedCrossRef
27.
Mitchell DG, Rao VM, Dalinka MK, et al. Femoral head avascular necrosis: correlation of MR imaging, radiographic staging, radionuclide imaging, and clinical findings. Radiology 1987; 162: 709–715.PubMed
28.
Abe H, Nakamura M, Takahashi S, Maruoka S, Ogawa Y, Sakamoto K. Radiation-induced insufficiency fractures of the pelvis: evaluation with 99mTc-methylene diphosphonate scintigraphy. Am J Roentgenol 1992; 158: 599–602.
29.
Blomlie V, Lien HH, Iversen T, Winderen M, Tvera K. Radiation-induced insufficiency fractures of the sacrum: evaluation with MR imaging. Radiology 1993; 188: 241–244.PubMed
30.
Mammone JF, Schweitzer ME. MRI of occult sacral insufficiency fractures following radiotherapy. Skeletal Radiol 1995; 24: 101–104.PubMedCrossRef
31.
Libshitz HI, Cohen MA. Radiation-induced osteochondromas. Radiology 1982; 142: 643–647.PubMed
32.
Weatherby RP, Dahlin DC, Ivins JC. Postradiation sarcoma of bone: review of 78 Mayo Clinic cases. Mayo Clin Proc 1981; 56: 294–306.PubMed
33.
Shaheen M, Deheshi BM, Riad S, et al. Prognosis of radiation-induced bone sarcoma is similar to primary osteosarcoma. Clin Orthop Relat Res 2006; 450: 76–81.PubMedCrossRef
34.
Kuttesch JF, Wexler LH, Marcus RB, et al. Second malignancies after Ewing’s sarcoma: radiation dose-dependency of secondary sarcomas. J Clin Oncol 1996; 14: 2818–2825.PubMed
35.
Inoue YZ, Frassica FJ, Sim FH, Unni KK, Petersen IA, McLeod RA. Clinicopathologic features and treatment of postirradiation sarcoma of bone and soft tissue. J Surg Oncol 2000; 75: 42–50.PubMedCrossRef
36.
Altehoefer C, Laubenberger J, Lange W, et al. Prospective evaluation of bone marrow signal changes on magnetic resonance tomography during high-dose chemotherapy and peripheral blood stem cell transplantation in patients with breast cancer. Invest Radiol 1997; 32: 613–620.PubMedCrossRef
37.
38.
Hirbe A, Morgan EA, Uluckan O, Weilbaecher K. Skeletal complications of breast cancer therapies. Clin Cancer Res 2006; 12: 6309s–6314s.PubMedCrossRef
39.
Woo SB, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med 2006; 144: 753–761.PubMed
40.
Wood J, Bonjean K, Ruetz S, et al. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 2002; 302: 1055–1061.PubMedCrossRef
41.
Fletcher BD, Wall JE, Hanna SL. Effect of hematopoietic growth factors on MR images of bone marrow in children undergoing chemotherapy. Radiology 1993; 189: 745–751.PubMed
42.
Ryan SP, Weinberger E, White KS, et al. MR imaging of bone marrow in children with osteosarcoma: effect of granulocyte colony-stimulating factor. Am J Roentgenol 1995; 165: 915–920.
43.
Hartman RP, Sundaram M, Okuno SH, Sim FH. Effect of granulocyte-stimulating factors on marrow of adult patients with musculoskeletal malignancies: incidence and MRI findings. Am J Roentgenol 2004; 183: 645–653.
44.
Panicek DM, Schwartz LH. MR imaging of bone marrow in patients with musculoskeletal tumors. Sarcoma 1999; 3: 37–41.CrossRef
45.
Hanna SL, Fletcher BD, Fairclough DL, Jenkins JH, Le AH. Magnetic resonance imaging of disseminated bone marrow disease in patients treated for malignancy. Skeletal Radiol 1991; 20: 79–84.PubMedCrossRef
46.
Holscher HC, Bloem JL, Nooy MA, Taminiau AH, Eulderink F, Hermans J. The value of MR imaging in monitoring the effect of chemotherapy on bone sarcomas. Am J Roentgenol 1990; 154: 763–769.
47.
Yasumoto M, Nonomura Y, Yoshimura R, et al. MR detection of iliac bone marrow involvement by malignant lymphoma with various MR sequences including diffusion-weighted echo-planar imaging. Skeletal Radiol 2002; 31: 263–269.PubMedCrossRef
48.
Gerard EL, Ferry JA, Amrein PC, et al. Compositional changes in vertebral bone marrow during treatment for acute leukemia: assessment with quantitative chemical shift imaging. Radiology 1992; 183: 39–46.PubMed
49.
Vande Berg BC, Michaux L, Scheiff JM, et al. Sequential quantitative MR analysis of bone marrow: differences during treatment of lymphoid versus myeloid leukemia. Radiology 1996; 201: 519–523.
50.
Dyke JP, Panicek DM, Healey JH, et al. Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology 2003; 228: 271–278.PubMedCrossRef
51.
Lecouvet FE, Vande Berg BC, Michaux L, et al. Chronic lymphocytic leukemia: changes in bone marrow composition and distribution assessed with quantitative MRI. J Magn Reson Imaging 1998; 8: 733–739.PubMedCrossRef
52.
Le Bihan DJ. Differentiation of benign versus pathologic compression fractures with diffusion-weighted MR imaging: a closer step toward the “holy grail” of tissue characterization? [editorial]. Radiology 1998; 207: 305–307.PubMed
53.
Wismer GL, Rosen BR, Buxton R, Stark DD, Brady TJ. Chemical shift imaging of bone marrow: preliminary experience. Am J Roentgenol 1985; 145: 1031–1037.
54.
Rosen G, Caparros B, Huvos AG. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982; 49: 1221–1230.PubMedCrossRef
55.
Meyers PA, Gorlick R, Heller G, et al. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. J Clin Oncol 1998; 16: 2452–2458.PubMed
56.
Lauenstein TC, Goehde SC, Herborn CU, et al. Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. Am J Roentgenol 2002; 179: 445–449.
57.
Johnston C, Brennan S, Ford S, Eustace S. Whole body MR imaging: applications in oncology. Eur J Surg Oncol 2006; 32: 239–246.PubMedCrossRef
58.
Ghanem N, Lohrmann C, Engelhardt M, et al. Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol 2006; 16: 1005–1014.PubMedCrossRef
59.
60.
Lauenstein TC, Goehde SC, Herborn CU, et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology 2004; 233: 139–148.PubMedCrossRef
61.
Ghanem N, Altehoefer C, Kelly T, et al. Whole-body MRI in comparison to skeletal scintigraphy in detection of skeletal metastases in patients with solid tumors. In Vivo 2006; 20: 173–182.PubMed
Metadata
Title
Magnetic resonance imaging of bone marrow in oncology, Part 2
Authors
Sinchun Hwang
David M. Panicek
Publication date
01-11-2007
Publisher
Springer-Verlag
Published in
Skeletal Radiology / Issue 11/2007
Print ISSN: 0364-2348
Electronic ISSN: 1432-2161
DOI
https://doi.org/10.1007/s00256-007-0308-4

Other articles of this Issue 11/2007

Skeletal Radiology 11/2007 Go to the issue

Perspective

Imaging in shoulder disorders

Case Report

Fibrogenesis imperfecta ossium: MR imaging of the axial and appendicular skeleton and correlation with a unique radiographic appearance

Scientific Article

Chronic exertional compartment syndrome of the lower extremities: improved screening using a novel dual birdcage coil and in-scanner exercise protocol

Scientific Article

Optimization of b value in diffusion-weighted MRI for the differential diagnosis of benign and malignant vertebral fractures

Case Report

Carpal-tarsal osteolysis with elbow involvement

Browser's Notes

Browser’s notes